An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.



Source link

LIKE TO GET ALERT ON LATEST AGRIBUSINESS NEWS & OPPORTUNITIES? CLICK TO DOWNLOAD THE AGRICULTURAL BUSINESS ANDROID APP ON GOOGLE PLAY